Kinésithérapie et COVID-19: de la réanimation à la réhabilitation à domicile. Synthèse des recommandations internationales
P Smondack, FÉ Gravier, G Prieur, A Repel… - Revue des maladies …, 2020 - Elsevier
Résumé Introduction La pathologie connue sous le nom de Coronavirus Disease 2019
(COVID-19) est responsable d'une pandémie mondiale et de nombreux décès. Ce contexte …
(COVID-19) est responsable d'une pandémie mondiale et de nombreux décès. Ce contexte …
Impact of the COVID-19 pandemic on the management of chronic noninfectious respiratory diseases
Introduction: The COVID-19 pandemic has challenged health care across the world, not just
by the severity of the disease and the high mortality rate but also by the consequences on …
by the severity of the disease and the high mortality rate but also by the consequences on …
High-risk airway management in the emergency department. Part I: diseases and approaches
Background Successful airway management is critical to the practice of emergency
medicine. Emergency physicians must be ready to optimize and prepare for airway …
medicine. Emergency physicians must be ready to optimize and prepare for airway …
National clinical audit for hospitalised exacerbations of COPD
Introduction Exacerbations of COPD requiring hospital admission are burdensome to
patients and health services. Audit enables benchmarking performance between units and …
patients and health services. Audit enables benchmarking performance between units and …
Clinical practice of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease
J Elshof, JM Vonk, A van der Pouw, C van Dijk… - Respiratory …, 2023 - Springer
Background Non-invasive ventilation (NIV) is an evidence-based treatment for acute
respiratory failure in chronic obstructive pulmonary disease (COPD). However, suboptimal …
respiratory failure in chronic obstructive pulmonary disease (COPD). However, suboptimal …
High‐Flow Nasal Oxygen versus Noninvasive Ventilation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients: A Meta‐Analysis of Randomized …
Y Du, H Zhang, Z Ma, J Liu, Z Wang… - Canadian …, 2023 - Wiley Online Library
Background. High‐flow nasal cannula (HFNC) can be used in stable chronic obstructive
pulmonary disease (COPD) patients, but the effect of HFNC on clinical outcomes in patients …
pulmonary disease (COPD) patients, but the effect of HFNC on clinical outcomes in patients …
Nutrition therapy in non-intubated patients with acute respiratory failure
N Sbaih, K Hawthorne, J Lutes, R Cavallazzi - Current Nutrition Reports, 2021 - Springer
Purpose of Review A challenging aspect of the care for patients with acute respiratory failure
is their nutrition management. This manuscript consists of a literature review on nutrition …
is their nutrition management. This manuscript consists of a literature review on nutrition …
[HTML][HTML] The use of high-flow nasal cannula in patients with chronic obstructive pulmonary disease under exacerbation and stable phases: a systematic review and …
H Yang, D Huang, J Luo, Z Liang, J Li - Heart & Lung, 2023 - Elsevier
Background High-flow nasal cannula (HFNC) has been increasingly utilized in patients with
chronic obstructive pulmonary disease (COPD); however, the effects on reducing the need …
chronic obstructive pulmonary disease (COPD); however, the effects on reducing the need …
Nasal high‐flow therapy compared with non‐invasive ventilation in COPD patients with chronic respiratory failure: a randomized controlled cross‐over trial
S McKinstry, J Singer, JP Baarsma, M Weatherall… - …, 2019 - Wiley Online Library
Background and objective Non‐invasive ventilation (NIV) is part of the standard of care for
hypercapnic respiratory failure secondary to COPD, but may be poorly tolerated. Preliminary …
hypercapnic respiratory failure secondary to COPD, but may be poorly tolerated. Preliminary …
Critical care of the adult patient with cystic fibrosis
Cystic fibrosis (CF) is a multiorgan, genetic disease resulting from dysfunction of the CF
transmembrane conductance regulator. The primary clinical manifestations are …
transmembrane conductance regulator. The primary clinical manifestations are …